NRG Therapeutics is a startup based in the United States, most recent round Series A, 2 tracked investors.
NRG Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
NRG Therapeutics is a drug discovery company targeting mitochondrial dysfunction to slow or prevent the progression of neurodegenerative diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.